Primary CNS plasmablastic lymphoma in an HIV/EBV negative patient: A case report

Diagn Cytopathol. 2016 Jan;44(1):61-5. doi: 10.1002/dc.23374. Epub 2015 Oct 15.

Authors

Martha Romero¹, Guido R González-Fontal², Carlos Saavedra¹, Joaquín Guerra^{2

3}, Guillermo Quintero⁴, Sandra Quijano¹, Douglas Ney⁵, Andrés F Henao-Martínez⁶

Affiliations

¹ Department of Pathology, Fundación Santa Fe De Bogotá, Bogotá, Colombia.
² Division of Hemato-Oncology, Universidad Militar Nueva Granada, Bogotá, Colombia.
³ Department of Hematology, Fundación Cardio Infantil, Bogotá, Colombia.
⁴ Department of Hematology, Fundación Santa Fe De Bogotá, Bogotá, Colombia.
⁵ Division of Hemato-Oncology, University of Colorado Denver, Denver, Colorado.
⁶ Division of Infectious Diseases, University of Colorado Denver, Denver, Colorado.

PMID: 26468050
DOI: 10.1002/dc.23374

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Biomarkers, Tumor / genetics*
Central Nervous System Neoplasms / diagnosis*
Central Nervous System Neoplasms / pathology
Central Nervous System Neoplasms / therapy
Frontal Lobe / drug effects
Frontal Lobe / pathology
Frontal Lobe / radiation effects
Gamma Rays / therapeutic use*
Gene Expression
HIV
Herpesvirus 4, Human
Humans
Male
Plasma Cells / pathology*
Plasmablastic Lymphoma / diagnosis*
Plasmablastic Lymphoma / pathology
Plasmablastic Lymphoma / therapy
Proto-Oncogene Proteins c-myc / genetics
Tumor Suppressor Protein p53 / genetics

Substances

Biomarkers, Tumor
MYC protein, human
Proto-Oncogene Proteins c-myc
Tumor Suppressor Protein p53